Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

Borghetti, Alberto; Lombardi, Francesca; Gagliardini, Roberta; Baldin, Gianmaria; Ciccullo, Arturo; Moschese, Davide; Emiliozzi, Arianna; Belmonti, Simone; Lamonica, Silvia; Montagnani, Francesca; Visconti, Elena; De Luca, Andrea; Di Giambenedetto, Simona

doi:10.1186/s12879-018-3666-8

BMC Infectious Diseases

Article metrics
Last updated: Fri, 19 Apr 2024 23:11:36 Z

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

Access & Citations

4882

Article Accesses
20

Web of Science
21

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com